ACSL6 antibody (AA 240-270)

Catalog No. ABIN5647457

This anti-ACSL6 antibody is a Rabbit Polyclonal antibody detecting ACSL6 in WB, ELISA and IHC. Suitable for Human and Mouse.

Quick Overview for ACSL6 antibody (AA 240-270) (ABIN5647457)

Target: ACSL6 (Acyl-CoA Synthetase Long-Chain Family Member 6 (ACSL6))

Reactivity: Human, Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This ACSL6 antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Product Details anti-ACSL6 Antibody

Binding Specificity: AA 240-270

Purification: Purified

Immunogen: A portion of amino acids 240-270 from the human protein was used as the immunogen for this ACSL6 antibody.

Isotype: Ig Fraction

Application Details

Application Notes: Western blot: 1:1000,IHC (Paraffin): 1:50-1:100

Restrictions: For Research Use only

Handling

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Aliquot the ACSL6 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Target Details for ACSL6

Target: ACSL6 (Acyl-CoA Synthetase Long-Chain Family Member 6 (ACSL6))

Alternative Name: ACSL6 / FACL6

Background: FACL6 is involved in activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. It plays an important role in fatty acid metabolism in brain and the acyl-CoAs produced may be utilized exclusively for the synthesis of the brain lipid. FACL6 is expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derieved from fetal liver, haemopoietic stem cells from cord blood, bone marrow, and brain. Expression is low at earlier stages of erythroid development but is very high in reticulocytes. This protein is involved in myelodysplastic syndrome (MDS) with basophilia, acute myelogenous leukemia (AML) with eosinophilia, and acute eosinophilic leukemia (AEL). It is characterized by a chromosomal translocation t(5,12)(q31,p13) that involves ETV6 and ACSL6.

UniProt: Q9UKU0